Profiles a dual ex vivo and clinical study testing an oral combination of an antioxidant, collagen peptides, and hyaluronate for improving facial skin aging signs and biomarkers.
Key Takeaways
- Triple combination reversed UV-induced epidermal thinning and collagen fiber disruption ex vivo
- Treatment up-regulated Nrf2 and SOD2 while lowering IL-1α, IL-6, and MMP1 expression ex vivo
- Oral administration improved skin hydration, elasticity, barrier function, and reduced wrinkle metrics in Chinese women